 DALLAS, Nov. 12, 2021 GLOBE NEWSWIRE -- Rapid Therapeutics Science Laboratories OTC: RTSL Rapid Therapeutic or the Company, a growth-oriented aerosol manufacturing company focused on delivery of non-psychoactive cannabinoid compounds, announces today that Chief Executive Officer Donal Schmidt will present a corporate overview at the Q4 Investor Summit Conference, which is being held virtually on November 16 17, 2021. 